Ruth E. Feltell

1.1k total citations
6 papers, 232 citations indexed

About

Ruth E. Feltell is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ruth E. Feltell has authored 6 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Ruth E. Feltell's work include Cancer-related Molecular Pathways (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Ruth E. Feltell is often cited by papers focused on Cancer-related Molecular Pathways (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Ruth E. Feltell collaborates with scholars based in United Kingdom and United States. Ruth E. Feltell's co-authors include John F. Lyons, Neil T. Thompson, David M. Cross, Nicola G. Wallis, Matthew Squires, Edward J. Lewis, Donna-Michelle Smith, Matthias Reule, Brent Graham and Hayley C. Angove and has published in prestigious journals such as Blood, PLoS ONE and Archives of Biochemistry and Biophysics.

In The Last Decade

Ruth E. Feltell

6 papers receiving 227 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruth E. Feltell United Kingdom	4	130	104	65	46	26	6	232
Christa L. Borgman United States	5	203 1.6×	126 1.2×	118 1.8×	26 0.6×	48 1.8×	5	325
David A. Kircher United States	8	197 1.5×	108 1.0×	70 1.1×	28 0.6×	32 1.2×	11	268
Shanhu Hu United States	8	135 1.0×	133 1.3×	91 1.4×	52 1.1×	31 1.2×	18	237
Theresa Manz United States	4	223 1.7×	123 1.2×	52 0.8×	45 1.0×	14 0.5×	6	285
Liv Johannessen United States	8	241 1.9×	152 1.5×	57 0.9×	27 0.6×	25 1.0×	19	374
Edward J. Lewis United Kingdom	5	223 1.7×	150 1.4×	77 1.2×	40 0.9×	15 0.6×	5	360
Donna-Michelle Smith United Kingdom	9	151 1.2×	213 2.0×	100 1.5×	65 1.4×	57 2.2×	12	363
Calvo Medina United States	6	239 1.8×	164 1.6×	33 0.5×	31 0.7×	19 0.7×	7	339
Victoria Lock United Kingdom	9	207 1.6×	187 1.8×	73 1.1×	126 2.7×	30 1.2×	11	353
Simon Bayle United States	5	173 1.3×	120 1.2×	64 1.0×	18 0.4×	29 1.1×	10	251

Countries citing papers authored by Ruth E. Feltell

Since Specialization

Citations

This map shows the geographic impact of Ruth E. Feltell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth E. Feltell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth E. Feltell more than expected).

Fields of papers citing papers by Ruth E. Feltell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth E. Feltell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth E. Feltell. The network helps show where Ruth E. Feltell may publish in the future.

Co-authorship network of co-authors of Ruth E. Feltell

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth E. Feltell. A scholar is included among the top collaborators of Ruth E. Feltell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth E. Feltell. Ruth E. Feltell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Foster, Rebecca R., Sue Griffin, Ruth E. Feltell, et al.. (2012). Multiple Metabolic Alterations Exist in Mutant PI3K Cancers, but Only Glucose Is Essential as a Nutrient Source. PLoS ONE. 7(9). e45061–e45061. 15 indexed citations

2.

Graham, Brent, Jayne Curry, Tomoko Smyth, et al.. (2011). The heat shock protein 90 inhibitor, AT13387, displays a long duration of action in vitro and in vivo in non‐small cell lung cancer. Cancer Science. 103(3). 522–527. 65 indexed citations

3.

Squires, Matthew, Ruth E. Feltell, Nicola G. Wallis, et al.. (2009). Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines. Molecular Cancer Therapeutics. 8(2). 324–332. 134 indexed citations

4.

Lyons, John F., Steven J. Woodhead, Ruth E. Feltell, et al.. (2007). AT13148, an orally bioavailable AKT kinase inhibitor with potent anti-tumor activity in both in vitro and in vivo models exhibiting AKT pathway deregulation.. Molecular Cancer Therapeutics. 6. 2 indexed citations

5.

Squires, Matthew, Ruth E. Feltell, Victoria Lock, et al.. (2007). AT7519, a Potent CDK Inhibitor, Is Active in Leukemia Models and Primary CLL Patient Samples.. Blood. 110(11). 3127–3127. 2 indexed citations

6.

Bunning, R.A.D., Ruth E. Feltell, Chih Min Kam, et al.. (1998). A Serine Proteinase Inactivator Inhibits Chondrocyte-Mediated Cartilage Proteoglycan Breakdown Occurring in Response to Proinflammatory Cytokines. Archives of Biochemistry and Biophysics. 355(1). 15–25. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact